Closed
SectorHealthcare
4.49 -7.04
24h
Min
4.41
Max
4.53
Income | -146M -31M |
---|---|
Sales | -105M 189M |
EPS | -0.578 |
Profit margin | -16.535 |
Employees | 900 |
EBITDA | -164M 13M |
Recommendations | Buy |
---|---|
12 Months Forecast | +231.86% upside |
Next Earnings | 30 kwi 2025 |
---|
Market Cap | 420M 540M |
---|---|
Previous open | 11.53 |
Previous close | 4.49 |
By Acuity
50%
50%
133 / 386 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 15 USD 231.86%
High 15 USD
Low 15 USD
Based on 1 Wall Street analysts offering 12 month price targets forEmergent BioSolutions Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$